Biocon launches colon cancer drug in India, priced Rs 24,000 Ruby Khatun Khatun24 Nov 2017 10:01 AM ISTBengaluru: Biocon Ltd has launched KRABEVA, a biosimilar Bevacizumab for the treatment of patients with metastatic colorectal cancer and other types...